Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study
- 1*,
- 1,
- 1,
- 1
- 1Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India Research Paper.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sandeep Grover
Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India Research Paper.
Email: drsandeepg2002@yahoo.com
Copyright: © 2012 The Author(s). This is an open access article.
Abstract
Objective: To study the prevalence and patterns of sexual dysfunctions in female patients receiving antidepressants. Materials and Methods: Eighty married female patients with a diagnosis of depressive disorder, currently in remission, and receiving a single antidepressant at least for 3 months, were assessed for sexual dysfunction on female sexual function index (FSFI) scale. Results: Thirty four patients (42.5%) receiving antidepressants had FSFI score less than 26.55 and were considered to have sexual dysfunction. When only the domain cutoff scores were used for the whole study sample (n=80), it was found that 95% had decreased desire, 60% had decreased arousal, 37.5% had decreased lubrication, 63.8 had decreased orgasm, 55% had decreased satisfaction and 25% had pain during sexual activity. Conclusions: To conclude, our study suggests that sexual dysfunction is quite prevalent in married female patients receiving antidepressants and all the domains of sexual functioning are impaired by antidepressants.
Keywords
Subject
Recommended articles
- Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting – a retrospective case series
Kingshuk Lahon, Harsha M. Shetty, Amith Paramel · Journal of Pharmacology and Pharmacotherapeutics
- Exploring the Novel Therapeutic Potential of N-acetylcysteine in Depression, Bipolar Disorders and Anxiety
Reuben P. Syiem, Julie B. Wahlang, Krishnamoorthi R. · Journal of Pharmacology and Pharmacotherapeutics
- Paroxetine in the treatment of recurrent brief depressive disorder
Sathya Prakash, Piyali Mandal, Rajesh Sagar · Journal of Pharmacology and Pharmacotherapeutics
- Effect of rolipram, a phosphodiesterase enzyme type– 4 inhibitor, on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress
Amany Mohamed Shalaby, Sahar Mohamed Kamal · Journal of Pharmacology and Pharmacotherapeutics
- Antidepressant‑like effect of a novel 5‑HT3 receptor antagonist N‑(benzo[d] thiazol‑2‑yl)‑3‑ethoxyquinoxalin‑2‑carboxamide 6k using rodents behavioral battery tests
Yeshwant Kurhe, Radhakrishnan Mahesh, Thangaraj Devadoss · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026